19:59:08 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Ocumetics Technology Corp
Symbol OTC
Shares Issued 123,330,441
Close 2025-08-27 C$ 1.35
Market Cap C$ 166,496,095
Recent Sedar+ Documents

Ocumetics Technology to hold investor webinar Aug. 28

2025-08-27 20:18 ET - News Release

Mr. Dean Burns reports

OCUMETICS WEBINAR - ACCOMMODATING INTRAOCULAR LENS UPDATE

Ocumetics Technology Corp. will be holding a webinar to discuss the initial Ocumetics lens implantations.

The webinar details are as follows.

Date:  Thursday, Aug. 28, 2025

Time:  6 p.m. ET

Join Ocumetics director and chief executive officer Dean Burns for an exclusive webinar covering important updates on the company's first-in-human (FIH) study and what lies ahead.

Topics will include:

  1. Encouraging outcomes from initial surgeries;
  2. Next steps to complete the FIH study;
  3. Live Q&A (question-and-answer) session with Mr. Burns.

This is a timely opportunity to gain insight into the company's progress at this critical stage of development.

Reserve your spot now on the company's website.

About Ocumetics Technology Corp.

Ocumetics is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.

Ocumetics is in the preclinical study phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed an intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.